An observational, prospective, longitudinal study of outpatients with HF found collagen turnover biomarkers (e.g., MMP-2) combined with clinical, biochemical and echocardiographic characteristics can improve the predictive precision of cardiovascular prognosis at the time of diagnosis (33). The gene discussed is MMP2; the disease is hydrops fetalis.